The present study showed that the secondary immune response was triggered in HCC vaccine-immunized mice challenged with the homologous tumor cells, accompanied by the activation of T cells and NK cells, the elimination of Tregs, and enhanced recruitment of CD8+ T cells in tumor tissues (Fig. 4). The gene discussed is CD8A; the disease is neoplasm.